Personalized cancer diagnostics

Science

Volumn 334, Issue 6060, 2011, Pages 1217-1218

  Corless, Christopher L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; K RAS PROTEIN; DNA; TRANSCRIPTOME;

CANCER; COST-BENEFIT ANALYSIS; EXPERIMENTAL STUDY; TUMOR;

CANCER DIAGNOSIS; COLORECTAL CARCINOMA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; LUNG NON SMALL CELL CANCER; ONCOGENE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; COST; DNA SEQUENCE; ECONOMICS; EXOME; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; MUTATION; NEOPLASM; PILOT STUDY;

COSTS AND COST ANALYSIS; DNA, NEOPLASM; EXOME; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDIVIDUALIZED MEDICINE; MUTATION; NEOPLASMS; PILOT PROJECTS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 82755187074     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1216427     Document Type: Short Survey

References (5)

1. Z. Su et al., J. Mol. Diagn. 13, 74 (2011).
2. C. Beadling et al., J. Mol. Diagn. 13, 504 (2011).
3. R. J. Leary et al., Sci. Transl. Med. 2, 20ra14 (2010).
4. J. S. Welch et al., JAMA 305, 1577 (2011).
5. S. Roychowdhury et al., Sci. Transl. Med. 3, 111ra121 (2011).